Furthermore, we demonstrated the importance of GDF15 in prognosticating PAD outcomes through SHAP analysis, which showed that this biomarker was the most important predictive feature in the model, above other clinically important variables such as age, smoking status, and cardiovascular comorbidities. Here, GDF15 is linked to peripheral arterial disease.